Open Date
-
Close Date
-
Listing Date
-
Price Range
₹0.0 to ₹0.0
IPO Size
₹0.00 Cr
Exchange Symbols
Balaji Speciality Chemicals Ltd
Cutoff - Lot Size
Open Date
Close Date
Listing Date
Price Range
IPO Size
Exchange Symbols
Open Date
Close Date
Listing Date
Price Range
IPO Size
Exchange Symbols
Sole manufacturer of niche chemicals in India, including Ethylenediamine, Piperazine (Anhydrous), Diethylenetriamine, Amino Ethyl Ethanol Amines and Amino Ethyl Piperazine (source: CRISIL Report), with significant export potential.
Well positioned to capture industry tailwinds.
Rapidly developed a diversified global and Indian customer base.
Ability to leverage research and development capabilities and strategic guidance from our Corporate Promoter.
We are the sole manufacturer in India of niche chemicals such as Ethylenediamine, Piperazine (Anhydrous), Diethylenetriamine, Amino Ethyl Ethanol Amines and Amino Ethyl Piperazine, using the Monoethanol Amine process (Source: CRISIL Report). We are a subsidiary of Balaji Amines Limited, one of the leading manufacturers of aliphatic amines in India (Source: CRISIL Report). As of March 31, 2022, our product portfolio comprised five niche chemicals catering to a diverse range of end user industries, including speciality chemicals, agrochemicals; and pharmaceuticals across multiple applications.
Company Name | Balaji Speciality Chemicals Ltd |
Headquarter | Solapur |
investors@balajispecialitychemicals.com | |
Website | www.balajispecialitychemicals.com |
MUFG Intime India Pvt Ltd
Phone Number | 91-22-49186000 |
Email ID | paytm.ipo@linkintime.co.in |
Website | www.linkintime.co.in |
Initial public offering of up to [*] equity shares of face value of Rs. 2 each ("Equity Shares") of Balaji Speciality Chemicals Limited ("The Company" or the "Issuer") for cash at a price of Rs. [*] per equity share (including a premium of Rs. [*] per equity share) ("Offer Price") aggregating up to Rs. [*] crores ("Offer"). The offer comprises of a fresh issue of up to [*] equity shares aggregating up to Rs. 250.00 crores (the "Fresh Issue") and an offer for sale of up to 26,000,000 equity shares aggregating up to Rs. [*] crores comprising of up to 1,030,000 equity shares aggregating up to Rs. [*] crores by Ande Prathap Reddy, up to 5,600,000 equity shares aggregating up to Rs. [*] crores by Ande Srinivas Reddy, up to 1,900,000 equity shares aggregating up to Rs. [*] crores by Ram Reddy Dundurapu, up to 2,300,000 equity shares aggregating up to Rs. [*] crores by Rajeshwar Reddy Nomula, up to 660,000 equity shares aggregating up to Rs. [*] crores by Gaddam Hemanth Reddy, up to 2,250,000 equity shares aggregating up to Rs. [*] crores by Achanta Annapurna, up to 2,000,000 equity shares aggregating up to Rs. [*] crores by Dundurapu Vandana Reddy, up to 3,600,000 equity shares aggregating up to Rs. [*] crores by Ande Shakuntala Devi, up to 900,000 equity shares aggregating up to Rs. [*] crores by Gaddam Madhumathi, up to 1,300,000 equity shares aggregating up to Rs. [*] crores by Gaddam Tanmai Reddy, up to 2,100,000 equity shares aggregating up to Rs. [*] crores by Eeshan Reddy Nomula, up to 800,000 equity shares aggregating up to Rs. [*] crores by Nomula Deepti Rajeshwar Reddy, up to 780,000 equity shares aggregating up to Rs. [*] crores by Gaddam Laasya Reddy and up to 780,000 equity shares aggregating up to Rs. [*] crores by Gaddam Komali Reddy ("Selling Shareholders") ("Offer for Sale", and together with the fresh issue, the "Offer"). In accordance with and subject to regulation 33 of the sebi icdr regulations, the offer may include a reservation of up to [*] equity shares, aggregating up to Rs. [*] crores (constituting up to [*]% of the offer), for subscription by eligible employee(s) (the "Employee Reservation {Portion") and a reservation of up to [*] equity shares, aggregating up to Rs. [*] crores (constituting up to [*]% of the offer), for subscription by Balaji Amines shareholders (as defined hereinafter) ("Balaji Amines shareholder reservation portion"). The company and the selling shareholders, in consultation with the book running lead managers ("brlms"), may offer a discount of up to [*]% (equivalent to Rs. [*] per equity share) of the offer price to eligible employee(s) bidding in the employee reservation portion ("Employee Discount") and of up to [*]% (equivalent to Rs. [*] per equity share) of the offer price to Balaji Amines shareholder(s) bidding in the Balaji Amines shareholder reservation portion ("Shareholder Discount"), subject to necessary approvals, as may be required. The offer less the employee reservation portion and the Balaji Amines shareholder reservation portion is hereinafter referred to as "Net Offer". The offer and net offer shall constitute [*] % and [*]%, respectively, of the post-offer paid-up equity share capital of the company. The company, in consultation with the selling shareholders and the brlms, may consider undertaking a further issue of equity shares or any other instrument as may be permissible through a preferential issue or any other method as may be permitted in accordance with applicable law to any person(s), for a cash consideration aggregating up to Rs. 50.00 crores between the date of with the roc ("pre-ipo placement"), the pre-ipo placement, if undertaken, will be at a price to be decided by the company and the selling shareholders, in consultation with the brlms. If the pre-ipo placement is undertaken, the amount raised pursuant to such pre-ipo placement will be reduced from the amount of the fresh issue, subject to compliance with the sebi icdr regulations and the scrr. The price band and the minimum bid lot will be decided by the company.
Address: 2nd Floor Balaji Towers, No 9/1A/1 Hotgi Road, Solapur, Maharashtra, 413224
Phone: 91-217-2606006
Email: investors@balajispecialitychemicals.com
Website: www.balajispecialitychemicals.com
Open Date: -
Close Date: -
Issue Price: ₹
Get started with us today and
start building your wealth journey
*By clicking, I agree to the T&C and Whatsapp updates.
Congratulations,
Your Digital savings bank account opening journey is complete.